Minority Diabetes Reports
Wednesday, October 24th, 2012
Crusty foods may worsen heart problems associated with diabetes ACES: OCTOBER 22, 2012 URBANA – A University of Illinois study suggests avoiding cooking methods that produce the kind of crusty bits you’d find on a grilled hamburger, especially if you have diabetes and know you’re at increased risk for cardiovascular disease because of your diagnosis. “We […]
Minority Diabetes Reports
Wednesday, October 24th, 2012
Black Womens Health: October 18, 2012 October 18, 2012, Washington, D.C. – The Black Women’s Health Imperative (Imperative) is pleased to announce that we have received an award from the Centers for Disease Control and Prevention (CDC) to implement an evidence-based, lifestyle-change program to prevent type 2 diabetes among Black women in five states: California, Indiana, Michigan, […]
Minority Diabetes Reports
Wednesday, October 24th, 2012
Diabetes Care: October 15, 2012 The National Health and Nutrition Examination Survey 2005–2008 Current recommendations for the use of hemoglobin A1c (HbA1c) in diabetes screening and diagnosis aim to identify those at greatest risk for diabetic microvascular complications. However, there is current controversy regarding the clinical implications of ethnic differences in HbA1c values. The objective of […]
Clinical Trial News
Wednesday, October 24th, 2012
JAMA: 10/22/12 A Randomized Controlled Trial Background Legumes, including beans, chickpeas, and lentils, are among the lowest glycemic index (GI) foods and have been recommended in national diabetes mellitus (DM) guidelines. Yet, to our knowledge, they have never been used specifically to lower the GI of the diet. We have therefore undertaken a study of low-GI […]
Clinical Trial News
Wednesday, October 24th, 2012
NIH: October 19, 2012 Intervention stopped early in NIH-funded study of weight loss in overweight and obese adults with type 2 diabetes after finding no harm, but no cardiovascular benefits An intensive diet and exercise program resulting in weight loss does not reduce cardiovascular events such as heart attack and stroke in people with longstanding […]
Clinical Trial News
Wednesday, October 24th, 2012
Diabetes Care: October 18, 2012 OBJECTIVE To investigate concentration of plasma insulin glargine after its subcutaneous dosing compared with concentration of its metabolites 1 (M1) and 2 (M2) in subjects with type 2 diabetes. RESEARCH DESIGN AND METHODS Nine subjects underwent a 32-h euglycemic glucose clamp study (0.4 units/kg glargine after 1 week of daily glargine administration). Glargine, […]
Clinical Trial News
Wednesday, October 24th, 2012
Informa Healthcare: November 10, 2012 Use of antioxidant components is a new approach for improvement of insulin resistance (IR) as a main feature of type 2 diabetes and its complications. The aim of this study was to investigate the effects of broccoli sprouts powder (BSP) containing high concentration of sulphoraphane on IR in type 2 diabetic […]
Clinical Trial News
Wednesday, October 24th, 2012
The American Journal of Clinical Nutrition: November 3, 2012 A high dietary protein intake has been shown to blunt the deposition of intrahepatic lipids in high-fat- and high-carbohydrate-fed rodents and humans. Objective: The aim of this study was to evaluate the effect of essential amino acid supplementation on the increase in hepatic fat content induced by a […]
News
Wednesday, October 24th, 2012
OBSSR: 10/22/12 Brian Wansink Professor at Cornell University, discusses how a lot of eating habits can be changed by changing the environment in which people encounter food; moving the office candy dish farther away, for example, or serving meals on smaller plates. Engaging in “solutions-based research,” Wansink and his team are looking for ways to […]
News
Wednesday, October 24th, 2012
The Journal of Clinical Endocrinology & Metabolism: October 17, 2012 After failure of metformin monotherapy, many second-line, glucose-lowering therapies are available to treat people with type 2 diabetes. Objective: The objective of the study was to compare clinical outcomes using common alternative regimens. Design and Setting: This was a retrospective cohort study using data from the U.K.-based General […]